ConductScience.org, home

Paper34646385

Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.

Morand du Puch CB and 5 others. Theranostics, 2021. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept. Papers, record 34646385. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34646385

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.
PubMed
Journal
Theranostics
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2022-02-07
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morand du Puch CBChristophe Bounaix
2Vanderstraete MMathieu
3Giraud SStéphanie
4Lautrette CChristophe
5Christou NNiki
6Mathonnet MMuriel

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Precision MedicineMajor topic
Biological Assay
Biomarkers, Pharmacological
Biomarkers, Tumor
Humans
Medical Oncology
Pathology, Molecular

Source PubMed

Download CSV of topics

References186

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124649243Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stage II-III colorectal cancer.Mol Clin Oncol2013https://conductscience.org/library/papers/24649243PubMed
223959905Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo.Int J Cancer2014https://conductscience.org/library/papers/23959905PubMed
332348737Dark Side of Cytotoxic Therapy: Chemoradiation-Induced Cell Death and Tumor Repopulation.Trends Cancer2020https://conductscience.org/library/papers/32348737PubMed
422461093Pharmacogenetics: implementing personalized medicine.Clin Cases Miner Bone Metab2009https://conductscience.org/library/papers/22461093PubMed
522966306Chemosensitivity of lung cancer: Differences between the primary lesion and lymph node metastasis.Oncol Lett2010https://conductscience.org/library/papers/22966306PubMed
611911296Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.Anticancer Res2001https://conductscience.org/library/papers/11911296PubMed
725954633A comprehensive review on clinical applications of comet assay.J Clin Diagn Res2015https://conductscience.org/library/papers/25954633PubMed
825267064Direct chemosensitivity monitoring ex vivo on undissociated melanoma tumor tissue by impedance spectroscopy.Cancer Res2014https://conductscience.org/library/papers/25267064PubMed
924008432Considerations for the successful co-development of targeted cancer therapies and companion diagnostics.Nat Rev Drug Discov2013https://conductscience.org/library/papers/24008432PubMed
1012168915Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical response.Anticancer Res2002https://conductscience.org/library/papers/12168915PubMed
1119097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
1225665006A Big Bang model of human colorectal tumor growth.Nat Genet2015https://conductscience.org/library/papers/25665006PubMed
1331866766Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model.Cancer Cell Int2019https://conductscience.org/library/papers/31866766PubMed
1431862441Developments in zebrafish avatars as radiotherapy sensitivity reporters - towards personalized medicine.EBioMedicine2020https://conductscience.org/library/papers/31862441PubMed
1518955806Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay.J Korean Med Sci2008https://conductscience.org/library/papers/18955806PubMed
1627832950The chick embryo chorioallantoic membrane (CAM) assay.Reprod Toxicol2017https://conductscience.org/library/papers/27832950PubMed
1728945830Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.Ann Oncol2017https://conductscience.org/library/papers/28945830PubMed
1823332421Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer.Clin Colorectal Cancer2013https://conductscience.org/library/papers/23332421PubMed
199291821The usefulness of the ATP assay with serum-free culture for chemosensitivity testing of gastrointestinal cancer.Eur J Cancer1997https://conductscience.org/library/papers/9291821PubMed
2026536825Precision medicine for cancer with next-generation functional diagnostics.Nat Rev Cancer2015https://conductscience.org/library/papers/26536825PubMed

See all 186 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42926325Live-cell FRET imaging-based efficacy prediction of EGFR-TKIs in EGFR L858R-mutant NSCLC.Clin Transl Med2026https://conductscience.org/library/papers/42926325PubMed
42212169Re-evaluating breast malignant pleural effusion: toward evidence-based, precision-aligned care with organoids.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42212169PubMed
42040583The patient journey and guideline-concordant care in colorectal cancer-is current practice enough?Front Med (Lausanne)2026https://conductscience.org/library/papers/42040583PubMed
41828436Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.Int J Mol Sci2026https://conductscience.org/library/papers/41828436PubMed
41228245Functional Assays to Guide Personalized Oncological Treatment of Patients with Soft-Tissue Sarcomas.Cancers (Basel)2025https://conductscience.org/library/papers/41228245PubMed
41144783Fast enrichment and detection of circulating tumor cells from large volumes of whole blood of breast cancer patients utilizing a functionalized bioaffinity CTC filtration membrane.Int J Cancer2026https://conductscience.org/library/papers/41144783PubMed
40113943Lab-in-a-Fiber detection and capture of cells.Sci Rep2025https://conductscience.org/library/papers/40113943PubMed
39337925Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.Life (Basel)2024https://conductscience.org/library/papers/39337925PubMed
39100682Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms.Front Immunol2024https://conductscience.org/library/papers/39100682PubMed
38252369Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review.Mol Biol Rep2024https://conductscience.org/library/papers/38252369PubMed
38132201Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells.Diagnostics (Basel)2023https://conductscience.org/library/papers/38132201PubMed
37235664Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer.Sci Adv2023https://conductscience.org/library/papers/37235664PubMed
35879922Functional Drug Screening in the Era of Precision Medicine.Front Med (Lausanne)2022https://conductscience.org/library/papers/35879922PubMed
35406568Soft Tissue Sarcoma Study: Association of Genetic Alterations in the Apoptosis Pathways with Chemoresistance to Doxorubicin.Cancers (Basel)2022https://conductscience.org/library/papers/35406568PubMed
35328603
Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells.
Int J Mol Sci2022https://conductscience.org/library/papers/35328603PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34646385

GET https://conductscience.org/api/papers/v1/34646385/references?page=2